Alembic Pharma held a conference call with analysts to discuss the impact of the coronavirus pandemic. Listen to the entire call transcript here. Key takeaways:
- Seeing China supply chains normalize, as coronavirus cases fall in the country
- Currently not seeing impact on business across markets, in wait and watch mode but pharma industry is so far seeing relatively less negative effects
- Closely watching trials of coronavirus treatments for positive outcomes, particularly the chloroquine+azithromycin combination treatments